Pathstone Family Office’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $489K | Buy |
+17,557
| New | +$489K | ﹤0.01% | 1045 |
|
|
2023
Q1 | – | Sell |
-32,114
| Closed | -$1.19M | – | 1208 |
|
|
2022
Q4 | $1.19M | Buy |
32,114
+2,938
| +10% | +$109K | 0.01% | 704 |
|
|
2022
Q3 | $960K | Buy |
29,176
+14,487
| +99% | +$476K | 0.01% | 761 |
|
|
2022
Q2 | $463K | Buy |
14,689
+191
| +1% | +$6.02K | 0.01% | 610 |
|
|
2022
Q1 | $665K | Sell |
14,498
-97
| -0.7% | -$4.45K | 0.02% | 445 |
|
|
2021
Q4 | $895K | Hold |
14,595
| – | – | 0.02% | 363 |
|
|
2021
Q3 | $1.09M | Hold |
14,595
| – | – | 0.03% | 271 |
|
|
2021
Q2 | $1.35M | Buy |
14,595
+215
| +1% | +$19.9K | 0.04% | 211 |
|
|
2021
Q1 | $1.28M | Buy |
+14,380
| New | +$1.28M | 0.04% | 178 |
|